Carnitine Traffic in Cells. Link With Cancer

Area of Science:

• Oncology
• Cellular Metabolism
• Molecular Biology

Background:

• Cancer cells display remarkable metabolic flexibility, adapting to utilize various substrates for survival and proliferation.
• Tumors exhibit metabolic heterogeneity, with altered glucose, amino acid, and lipid metabolism.
• Fatty acid oxidation (FAO) is a key energy source in some cancers, relying on carnitine for mitochondrial entry.

Purpose of the Study:

• To investigate the role of carnitine transporters in cancer metabolic rewiring.
• To elucidate the mechanisms regulating carnitine transporter function and expression in tumors.
• To explore the therapeutic potential of targeting the carnitine network in cancer treatment.

Main Methods:

• Review of literature on carnitine metabolism and transporters in cancer.
• Analysis of the roles of specific plasma membrane (OCTN2, CT2, MCT9, ATB^{0, +}) and mitochondrial (CAC) carnitine transporters.
• Discussion of the carnitine network's contribution to cancer's metabolic adaptability.

Main Results:

• Carnitine is essential for fatty acid entry into mitochondria for oxidation (β-oxidation).
• Specific transporters (OCTN2, CT2, MCT9, ATB^{0, +}, CAC) mediate carnitine flux across cellular membranes.
• These transporters form a network crucial for cancer cell metabolic reprogramming.

Conclusions:

• The carnitine network is integral to cancer's metabolic flexibility and survival.
• Modulation of carnitine transporter expression and function is a key aspect of cancer metabolism.
• Targeting carnitine transporters presents a promising strategy for novel cancer therapies.